Patent ID: 6878386

Claim:
A method for treating a bacterial infection in a human in need thereof, which method comprises administering to said human, at a dosage regimen interval of about 12 hours, a dosage of about 2000 mg of amoxicillin and about 125 mg potassium clavulanate, in which the dosage is delivered from a modified release formulation, adapted to provide a mean maximum plasma concentration (C max ) of amoxicillin of at least 12 μg/ml, an Area under the Curve (AUC) value of amoxicillin which is at least 80% of that of the same amount if taken as an immediate release formulation over the same dosage regimen interval, and a mean plasma concentration of amoxicillin of at least 4 μg/ml for at least 4.2 hours, and further adapted to provide for immediate release of the potassium clavulanate.